| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
27,810 |
19,490 |
$1.76M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,709 |
14,384 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,167 |
2,320 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,587 |
3,166 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
707 |
293 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
477 |
269 |
$992.38 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,438 |
895 |
$972.41 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,792 |
1,197 |
$554.47 |
| 81003 |
|
2,134 |
1,490 |
$44.92 |
| 81025 |
|
848 |
604 |
$38.36 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
885 |
703 |
$0.00 |
| 87428 |
|
8,724 |
6,347 |
$0.00 |
| 87807 |
|
779 |
577 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
15 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
101 |
87 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,580 |
2,450 |
$0.00 |
| 99072 |
|
5,736 |
1,534 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
60 |
55 |
$0.00 |